POST-MORTEM CHARACTERISTICS OF HEPATIC MICROSOMAL DRUG OXIDIZING ENZYME-SYSTEM

[1] ACKERMANN E, 1970, Biochemical Pharmacology, V19, P327, DOI 10.1016/0006-2952(70)90190-5

[2] ALVARES AP, 1969, CLIN PHARMACOL THER, V10, P655

[3] COCHIN J, 1959, J PHARMACOL EXP THER, V125, P105

[4] CREAVEN PJ, 1963, BIOCHEM J, V87, pP19

[5] APPARENT MICHAELIS CONSTANTS FOR METABOLISM OF (UREYL-C-14)TOLBUTAMIDE BY HUMAN LIVER MICROSOMAL PREPARATIONS [J]. BIOCHEMICAL PHARMACOLOGY, 1972, 21 (03) : 407 - &

[6] HUMAN LIVER MICROSOMAL DRUG METABOLISM [J]. BIOCHEMICAL PHARMACOLOGY, 1970, 19 (04) : 1514 - &

[7] EFFECT OF DRUG SUBSTRATES ON REDUCTION OF HEPATIC MICROSOMAL CYTOCHROME P-450 BY NADPH [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1968, 31 (04) : 558 - &

[8] JONDORF W R, 1970, Research Communications in Chemical Pathology and Pharmacology, V1, P581

[9] KABAT EA, 1967, EXPTL IMMUNOCHEMISTR

[10] KATO R, 1965, J PHARMACOL EXP THER, V150, P279

[1] ACKERMANN E, 1970, Biochemical Pharmacology, V19, P327, DOI 10.1016/0006-2952(70)90190-5

[2] ALVARES AP, 1969, CLIN PHARMACOL THER, V10, P655

[3] COCHIN J, 1959, J PHARMACOL EXP THER, V125, P105

[4] CREAVEN PJ, 1963, BIOCHEM J, V87, pP19

[5] APPARENT MICHAELIS CONSTANTS FOR METABOLISM OF (UREYL-C-14)TOLBUTAMIDE BY HUMAN LIVER MICROSOMAL PREPARATIONS [J]. BIOCHEMICAL PHARMACOLOGY, 1972, 21 (03) : 407 - &

[6] HUMAN LIVER MICROSOMAL DRUG METABOLISM [J]. BIOCHEMICAL PHARMACOLOGY, 1970, 19 (04) : 1514 - &

[7] EFFECT OF DRUG SUBSTRATES ON REDUCTION OF HEPATIC MICROSOMAL CYTOCHROME P-450 BY NADPH [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1968, 31 (04) : 558 - &

[8] JONDORF W R, 1970, Research Communications in Chemical Pathology and Pharmacology, V1, P581

[9] KABAT EA, 1967, EXPTL IMMUNOCHEMISTR

[10] KATO R, 1965, J PHARMACOL EXP THER, V150, P279